 This results in a longer half-life of nilutamide in humans of 2 days.Nevertheless, the nitro anion-free radical formed during nitro reduction could still be associated with hepatotoxicity in humans, especially when using relatively high dosage employed for androgen blockage.Nilutamide causes side-effects which limit its usage, such as pneumonitis and delayed adaption to darkness.